IL190520A0 - Compositions and methods for treatment of autoimmune - Google Patents

Compositions and methods for treatment of autoimmune

Info

Publication number
IL190520A0
IL190520A0 IL190520A IL19052008A IL190520A0 IL 190520 A0 IL190520 A0 IL 190520A0 IL 190520 A IL190520 A IL 190520A IL 19052008 A IL19052008 A IL 19052008A IL 190520 A0 IL190520 A0 IL 190520A0
Authority
IL
Israel
Prior art keywords
autoimmune
compositions
treatment
methods
Prior art date
Application number
IL190520A
Other languages
English (en)
Original Assignee
Bayhill Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayhill Therapeutics Inc filed Critical Bayhill Therapeutics Inc
Publication of IL190520A0 publication Critical patent/IL190520A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0007—Nervous system antigens; Prions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
IL190520A 2005-10-05 2008-03-30 Compositions and methods for treatment of autoimmune IL190520A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72420305P 2005-10-05 2005-10-05
PCT/US2006/038776 WO2007044394A2 (en) 2005-10-05 2006-10-04 Compositions and methods for treatment of autoimmune disease

Publications (1)

Publication Number Publication Date
IL190520A0 true IL190520A0 (en) 2008-11-03

Family

ID=37943343

Family Applications (1)

Application Number Title Priority Date Filing Date
IL190520A IL190520A0 (en) 2005-10-05 2008-03-30 Compositions and methods for treatment of autoimmune

Country Status (9)

Country Link
US (1) US20100160415A1 (enExample)
EP (1) EP1931390B1 (enExample)
JP (1) JP2009511014A (enExample)
CN (1) CN101365494A (enExample)
AU (1) AU2006302477A1 (enExample)
CA (1) CA2624615A1 (enExample)
IL (1) IL190520A0 (enExample)
NZ (1) NZ567150A (enExample)
WO (1) WO2007044394A2 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL1668105T3 (pl) * 2003-09-29 2019-03-29 Deb Ip Limited Kompozycje żelopodobne i pieniące o dużej zawartości alkoholu
DE102004062775A1 (de) 2004-12-21 2006-06-29 Stockhausen Gmbh Alkoholischer Pumpschaum
CN101170904A (zh) 2005-03-07 2008-04-30 戴博全球保健有限公司 含有有机硅基表面活性剂的高醇含量发泡组合物
US20180092991A1 (en) * 2009-06-05 2018-04-05 Bayhill Therapeutics, Inc. Compositions and methods for treatment of insulin-dependent diabetes mellitus
EP2525825A1 (en) * 2010-01-20 2012-11-28 Bayhill Therapeutics, Inc. Combination therapy to treat autoimmune diseases
US9222107B2 (en) 2011-05-25 2015-12-29 National University Corporation Okayama University REIC-expressing adenovirus vector
KR101466874B1 (ko) * 2012-05-11 2014-12-03 가톨릭대학교 산학협력단 자가면역 질환의 예방과 치료를 위한 ｉｌ-６ 수용체에 대한 항체를 발현하는 미니서클
KR101466875B1 (ko) * 2012-05-11 2014-12-03 가톨릭대학교 산학협력단 항종양괴사인자 수용체 2를 발현하도록 설계된 미니서클 벡터를 이용한 자가면역질환 치료
ES2719691T3 (es) 2013-11-22 2019-07-12 Amarna Holding B V Procedimiento de restauración de tolerancia inmunitaria in vivo
US20160320384A1 (en) * 2013-12-31 2016-11-03 Yeda Research And Development Co. Ltd. Methods for assaying immunological competence
EP3090064B1 (en) 2013-12-31 2019-11-13 Yeda Research and Development Co. Ltd. Diagnosis of systemic lupus erythematosus using oligonucleotides antigens
US20170196949A1 (en) * 2014-06-04 2017-07-13 Diamyd Medical Ab Novel combinations for antigen based therapy
WO2016139659A1 (en) 2015-03-01 2016-09-09 Immunarray Ltd. Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleotide antigens
NZ749593A (en) * 2016-06-20 2025-10-31 Univ Leland Stanford Junior Circular rnas and their use in immunomodulation
HUE051766T2 (hu) 2016-11-01 2021-03-29 Novo Nordisk As Tolerogén DNS vakcina
US20210277417A1 (en) * 2018-06-25 2021-09-09 Akouos, Inc. Methods of treating clrn1-associated hearing loss and/or vision loss
US11279745B2 (en) 2019-04-26 2022-03-22 Novo Nordisk A/S Tolerogenic DNA vaccine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274136B1 (en) * 1996-05-29 2001-08-14 University Of Southern California Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease
JP2002520299A (ja) * 1998-07-09 2002-07-09 メルク エンド カムパニー インコーポレーテッド ポリヌクレオチドワクチン配合物
MXPA01007895A (es) * 1999-02-03 2003-07-21 Biosante Pharmaceuticals Inc Particulas terapeuticas de fosfato de calcio, metodos de manufactura y usos.
US7030098B2 (en) * 1999-03-12 2006-04-18 The Board Of Trustees Of The Leland Stanford Junior University DNA vaccination for treatment of autoimmune disease
US6479474B2 (en) * 1999-07-08 2002-11-12 Wisconsin Alumni Research Foundation Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis
CA2456821A1 (en) * 2001-08-02 2003-02-13 Trinity Biomedical Technology Corporation Human zona pellucida proteins and methods of their use in diagnosing male infertility
EP2301553A1 (en) * 2001-11-21 2011-03-30 The Board Of Trustees Of The Leland Stanford Junior University Polynucleotide therapy
US20040002537A1 (en) * 2002-03-29 2004-01-01 Zamvil Scott S. Use of statins in the treatment of autoimmune disease
ES2457022T3 (es) * 2003-10-10 2014-04-24 Powderject Vaccines, Inc. Construcciones de ácidos nucleicos

Also Published As

Publication number Publication date
EP1931390A4 (en) 2009-04-15
EP1931390B1 (en) 2012-07-25
CN101365494A (zh) 2009-02-11
WO2007044394A3 (en) 2007-07-12
US20100160415A1 (en) 2010-06-24
WO2007044394A2 (en) 2007-04-19
CA2624615A1 (en) 2007-04-19
AU2006302477A1 (en) 2007-04-19
EP1931390A2 (en) 2008-06-18
NZ567150A (en) 2011-12-22
JP2009511014A (ja) 2009-03-19

Similar Documents

Publication Publication Date Title
IL190520A0 (en) Compositions and methods for treatment of autoimmune
ZA200704677B (en) Compositions and methods for the treatment of autism
SI1791791T1 (sl) Postopki in sestavki za obdelavo vode
ZA200900388B (en) Compositions and methods for the treatment of mucositis
IL188237A0 (en) Compositions and methods for treatment of cycle-related symptoms
IL181896A0 (en) Methods and compositions for the treatment of hyperlipidemia
IL200766A0 (en) Compositions and methods for the prevention and treatment of autoimmune conditions
IL186963A0 (en) Methods and compositions for treating pain
SI2079760T1 (sl) Sestavki in metode za zdravljenje okužb
PT2101766T (pt) Composições e métodos de utilização de (r)-pramipexole
IL191072A0 (en) Therapeutic compositions and methods
IL197804A0 (en) Compositions for the trearment of hepatitis c and methods for using compositions for the treatment of hepatitis c
IL177849A0 (en) Methods and compositions for treatment of autoimmune diseases
PL2069467T3 (pl) Kompozycje wydzielające i sposoby stosowania
EP2049151A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER
EP1991270A4 (en) COMPOSITIONS AND METHODS FOR THE PREVENTION AND TREATMENT OF CACHEXIA
PL2101766T3 (pl) Kompozycje i sposoby stosowania (R)-pramipeksolu
IL186325A0 (en) Tizanidine compositions and methods of treatment using the compositions
EP1890712A4 (en) COMPOSITIONS AND METHODS FOR TREATING PAIN
IL187405A0 (en) Methods and compositions for the treatment of pain
IL196411A0 (en) Anti-cocaine compositions and treatment
EP1786265A4 (en) NEW COMPOSITIONS AND PROCESSING METHODS
ZA200703087B (en) Methods and compositions for the treatment of hyperlipidemia
EP1937075A4 (en) SYNERGIC COMPOSITION AND METHOD OF USE
IL180195A0 (en) Aequorin-containing compositions and methods of using same